Acurx Pharmaceuticals, Inc. (ACXP)
1.43
+0.01
(+0.70%)
USD |
NASDAQ |
Sep 08, 16:00
1.435
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals Market Cap : 6.697M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 6.697M |
| September 04, 2026 | 6.650M |
| September 03, 2026 | 6.557M |
| September 02, 2026 | 6.697M |
| September 01, 2026 | 6.557M |
| August 31, 2026 | 6.791M |
| August 28, 2026 | 6.744M |
| August 27, 2026 | 6.838M |
| August 26, 2026 | 6.697M |
| August 25, 2026 | 6.604M |
| August 24, 2026 | 6.557M |
| August 21, 2026 | 6.884M |
| August 20, 2026 | 6.791M |
| August 19, 2026 | 6.744M |
| August 18, 2026 | 6.744M |
| August 17, 2026 | 7.727M |
| August 14, 2026 | 6.533M |
| August 13, 2026 | 6.931M |
| August 12, 2026 | 7.212M |
| August 11, 2026 | 6.884M |
| August 10, 2026 | 5.185M |
| August 07, 2026 | 5.219M |
| August 06, 2026 | 4.948M |
| August 05, 2026 | 4.982M |
| August 04, 2026 | 4.846M |
| Date | Value |
|---|---|
| August 03, 2026 | 4.846M |
| July 31, 2026 | 4.880M |
| July 30, 2026 | 4.812M |
| July 29, 2026 | 4.711M |
| July 28, 2026 | 4.779M |
| July 27, 2026 | 4.846M |
| July 24, 2026 | 4.812M |
| July 23, 2026 | 4.914M |
| July 22, 2026 | 4.982M |
| July 21, 2026 | 5.151M |
| July 20, 2026 | 5.253M |
| July 17, 2026 | 5.253M |
| July 16, 2026 | 5.389M |
| July 15, 2026 | 5.931M |
| July 14, 2026 | 5.592M |
| July 13, 2026 | 5.355M |
| July 10, 2026 | 5.084M |
| July 09, 2026 | 4.948M |
| July 08, 2026 | 4.609M |
| July 07, 2026 | 4.914M |
| July 06, 2026 | 5.355M |
| July 02, 2026 | 5.423M |
| July 01, 2026 | 5.185M |
| June 30, 2026 | 5.253M |
| June 29, 2026 | 5.694M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.747B |
| Alnylam Pharmaceuticals, Inc. | 34.78B |
| Anika Therapeutics, Inc. | 281.58M |
| Savara, Inc. | 1.136B |
| Vericel Corp. | 2.000B |
Market Cap Related Metrics
| Price to Book Value | 0.8215 |
| Price | 1.43 |
| Earnings Yield | -213.0% |